ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis.

ABSTRACT: Cancer metastasis is largely incurable and accounts for 90% of breast cancer deaths, especially for the aggressive basal-like or triple negative breast cancer (TNBC). Combining patient database analyses and functional studies, we examined the association of integrin family members with clinical outcomes as well as their connection with previously identified microRNA regulators of metastasis, such as miR-206 that inhibits stemness and metastasis of TNBC. Here we report that the integrin receptor CD49b-encoding ITGA2, a direct target of miR-206, promotes breast cancer stemness and metastasis. ITGA2 knockdown suppressed self-renewal related mammosphere formation and pluripotency marker expression, inhibited cell cycling, compromised migration and invasion, and therefore decrease

SUBMITTER: Adorno-Cruz V 

PROVIDER: S-EPMC8209312 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature